Spectral Precise Image Study for Brain Tumors
ConditionBrain Tumors
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorPhilips Clinical & Medical Affairs Global
About this trial
The goal of this observational study is to explore the image quality of spectral CT deep learning reconstruction technology (Spectral Precise Image) of patients with confirmed brain tumors.
The main question it aims to answer is:
The Image Quality (IQ) and diagnostic confidence of Spectral Precise Image reconstructions
Eligibility criteria
Qualifiers
Patients with clinical and radiology (MRI/CT) diagnosed brain tumors.
Patients who underwent contrast enhanced scans using the Spectral CT 7500.
Study participants with age ≥ 18 years old.
Study participants that have signed Informed Consent Form (ICF)
Disqualifiers
The clinical data or radiological information is considered incomplete after evaluation by the investigator.
Study participant that was enrolled in this study in the past
Data from study participants deemed unsuitable for enrollment based on the investigator's evaluation
Trial design
Treatments tested in this trial
- This is an observational data collection study
Treatment groups
No treatment groups listed
Sponsors and collaborators
Philips Clinical & Medical Affairs Global
Lead sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Collaborator
Source ClinicalTrials.gov